Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
ALGS:NASDAQ
Aligos Therapeutics Inc
$5.71
-14.65%
(-0.98) 1D
$5.74
+0.53% (+0.030)
After hours
Closed: May 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALGS...
Open
$6.49
High
$6.66
Low
$5.68
Mkt. cap
35.33M
Avg. vol.
342.24K
Volume
179.28K
52-wk high
$13.69
52-wk low
$5.12
EPS
-$8.70
Beta
2.28
Shares outstanding
5.39M
No. of employees
82
News stories
From sources across the web
About Aligos Therapeutics Inc
CEO-
Employees82
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitealigos.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
965.00K
741.00K
169.00K
2.83M
Cost of goods sold
13.98M
23.94M
17.04M
-
Cost of revenue
13.98M
23.94M
17.04M
-
Research and development expenses
-
-
-
23.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.56M
5.16M
4.94M
6.41M
Operating expense
5.56M
5.16M
4.94M
29.76M
Total operating expenses
19.53M
29.10M
21.98M
29.76M
Operating income
-18.57M
-28.36M
-21.81M
-26.93M
Other non operating income
2.49M
-3.50M
1.22M
3.40M
EBT including unusual items
-15.68M
-31.48M
-19.85M
-22.72M
EBT excluding unusual items
-15.68M
-31.48M
-19.85M
-22.72M
Income tax expense
185.00K
56.00K
30.00K
317.00K
Effective tax rate
-1.18%
-0.18%
-0.15%
-1.40%
Other operating expenses
-
-
-
-
Net income
-15.86M
-31.54M
-19.88M
-23.04M
Net profit margin
-1,643.83%
-4,256.01%
-11,763.91%
-814.13%
Earnings per share
-1.53
-3.04
-1.91
-2.21
Interest and investment income
396.00K
378.00K
548.00K
811.00K
Interest expense
-
-
-
-
Net interest expenses
396.00K
378.00K
548.00K
811.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.31M
-28.14M
-21.56M
-26.58M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer